insights_auto
Why is CC up 2.89%?
Dive Deeperchevron_right
CC:NYSE
Chemours Co
$12.98
arrow_upward
+2.89%(+0.36) 1D
Oct 20, 2:23:39 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CC...
Open
$12.56
High
$13.06
Low
$12.52
Mkt. cap
1.95B
Avg. vol.
2.04M
Volume
1.36M
Dividend
2.70%
Quarterly dividend
$0.09
Ex-dividend date
Aug 14, 2026
52-wk high
$28.67
52-wk low
$10.44
EPS
-$2.01
Beta
1.41
Shares outstanding
150.50M
No. of employees
6K
Open
$12.56
High
$13.06
Low
$12.52
Mkt. cap
1.95B
Avg. vol.
2.04M
Volume
1.36M
Dividend
2.70%
Quarterly dividend
$0.09
Ex-dividend date
Aug 14, 2026
52-wk high
$28.67
52-wk low
$10.44
EPS
-$2.01
Beta
1.41
Shares outstanding
150.50M
No. of employees
6K
News stories
From web sources and news partners
ad-hoc-news.de
·
24 minutes ago
RBC cuts target for Chemours stock from USD 22.00 to USD 14.00
GlobeNewswire
·
3 hours ago
CC Investors Have Opportunity to Lead The Chemours Company Securities Fraud Lawsuit with SBS Law
Profile
The Chemours Company, headquartered in Wilmington, Delaware, is an American chemical company. It was spun off from DuPont in July 2015. The company's primary products are refrigerants, titanium dioxide pigment, and industrial fluoropolymer resins. The company operates 28 major production facilities in 8 countries and serves approximately 2,400 customers in approximately 110 countries.
Chemours manufactures and sells chemicals under three divisions: Thermal & Specialized Solutions, which produces refrigerants, thermal management products, propellants, foam blowing agents, and specialty solvents including Freon; Titanium Technologies, which produces titanium dioxide; and Advanced Performance Materials which produces membranes, industrial resins, and coatings under the brand names Teflon, Viton, Nafion, ECCtreme ECA, and Krytox.
Chemours is ranked the 594th on the Fortune 500 and 1534th on the Forbes Global 2000.
The name of the company is a portmanteau of the words "chemical" and "Nemours", derived from E. I. du Pont de Nemours & Co., the company's former parent.
The company has faced fines and regulations from its contamination of air, water, and soil with PFAS. Wikipedia
About Chemours Co
CEO-
Employees5.7K
FoundedJul 1, 2015
HeadquartersWilmington, Delaware, United States
SectorChemical industry
Websitechemours.com
Analyst ratings
Based on 10 analysts giving stock ratings to CC in the past 3 months
Buy
Buy
3
Hold
7
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for CC in the last 3 months.
Highest
Current $12.98
$22.00 (+69.43%)
Average
$17.10 (+31.69%)
Lowest
$14.00 (+7.82%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Pete Osterland Truist Financial | Buy | Maintained | $20.00 | +54% | 10/20/2026 |
John Roberts CFA Mizuho Securities | Hold | Downgraded | $15.00 | +15.5% | 10/13/2026 |
Arun Viswanathan RBC Capital | Hold | Downgraded | $14.00 | +7.8% | 10/12/2026 |
Michael Leithead Barclays | Hold | Initiated | $16.00 | +23.2% | 10/12/2026 |
Aleksey Yefremov Barclays | Hold | Initiated | $16.00 | +23.2% | 10/12/2026 |
John McNulty BMO Capital | Buy | Reiterated | $18.00 | +38.6% | 10/05/2026 |
Joshua Spector UBS | Hold | Maintained | $16.00 | +23.2% | 10/05/2026 |
Duffy Fischer Goldman Sachs | Hold | Maintained | $17.00 | +30.9% | 08/24/2026 |
Hassan Ahmed Alembic Global | Buy | Maintained | $22.00 | +69.4% | 08/19/2026 |
Jeffrey Zekauskas J.P. Morgan | Hold | Maintained | $15.00 | +15.5% | 08/17/2026 |
Vincent Andrews Morgan Stanley | Hold | Reiterated | $18.00 | +38.6% | 08/10/2026 |
Last report
Aug 5, 2026
Fiscal period
Q2 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
$0.42 / $0.42
+0.07%beat
arrow_upward
Revenue / Est. (USD)
1.59B / 1.66B
-3.95%miss
arrow_downward
Fiscal Q2 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 1.50B | 1.33B | 1.38B | 1.59B |
Cost of goods sold | 1.26B | 1.17B | 1.17B | 1.30B |
Cost of revenue | 1.26B | 1.17B | 1.17B | 1.30B |
Research and development expenses | 26.00M | 27.00M | 26.00M | 27.00M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 105.00M | 105.00M | 145.00M | 241.00M |
Operating expense | 131.00M | 132.00M | 171.00M | 268.00M |
Total operating expenses | 1.39B | 1.30B | 1.34B | 1.57B |
Operating income | 104.00M | 27.00M | 41.00M | 18.00M |
Other non operating income | 6.00M | 4.00M | 19.00M | 5.00M |
EBT including unusual items | 51.00M | -67.00M | -22.00M | -1.00M |
EBT excluding unusual items | 50.00M | -33.00M | - | -37.00M |
Income tax expense | -9.00M | -5.00M | 7.00M | 273.00M |
Effective tax rate | -17.65% | 7.46% | -31.82% | -27,300.00% |
Other operating expenses | - | - | - | - |
Net income | 60.00M | -61.00M | -29.00M | -274.00M |
Net profit margin | 4.01% | -4.59% | -2.10% | -17.22% |
Earnings per share | 0.20 | 0.05 | 0.05 | 0.42 |
Interest and investment income | - | - | - | - |
Interest expense | -68.00M | -68.00M | -69.00M | -68.00M |
Net interest expenses | -68.00M | -68.00M | -69.00M | -68.00M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 183.00M | 131.00M | 120.00M | 98.00M |
Gain or loss from assets sale | -7.00M | - | - | -266.00M |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1